PER 0.00% 10.5¢ percheron therapeutics limited

For General Information, page-1872

  1. 1,031 Posts.
    lightbulb Created with Sketch. 104
    Dont expect any BIG announcements soon٠٠٠as suspected.

    The only latest response from the company after asking was that there had been some significant changes required in the clinical development strategy for ATL 1102 in DMD but are close to initiating the phase 2b trial and will update the market soon٠٠

    Read what you will into this reply from them.

    Zig٠٠
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.